Landos Biopharma
Presence
Landos Biopharma is a company listed under the stock ticker LABP (US).
Executives
View the org chart displaying its 8 main executives
Most searched biographies at Landos Biopharma
- Gregory Oakes, Director, President and Chief Executive Officer
- Tiago Girão, Director
- Chris Garabedian, Chairman of the Board
Create your alert
to follow the executive moves at Landos Biopharma.
Biotechnology
Landos Biopharma has 2,276 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
Popular contacts in Biotechnology
News
Press releases by Landos Biopharma
- Landos Biopharma Reports Positive Top-Line Results From NX-13 Phase 1b Trial | Landos Biopharma
- Landos Names Gregory Oakes President and Chief Executive Officer | Landos Biopharma
- Landos Biopharma Reports First Quarter 2022 Results and Provides Business Update | Landos Biopharma
- Landos Biopharma Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update | Landos Biopharma
- Landos Biopharma Appoints Roger Adsett to its Board of Directors | Landos Biopharma
- Landos Biopharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update | Landos Biopharma
- Landos Biopharma to Host Corporate Update Call | Landos Biopharma
- View more press releases Close
Social media about Landos Biopharma
- Landos Biopharma on Wikipedia, Google News & Yahoo Finance
- Landos Biopharma on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Chris Garabedian 
Call Landos Biopharma at +1 540...
